Post by MIDC

Molecule to Markets: Maharashtra’s Pharma & Biotech Edge The insightful sectoral discussion that brought together some of the sharpest minds in the pharma and biotech space! Moderated by Mr. Nitin G Soundale (PwC), the panel featured industry leaders: Mr. Satish Wagh (Supriya Lifesciences) Mr. Dhananjay Singh (Merck) Ms. Aditi Kare Panandikar (Indoco) Mr. Hitesh Kumar Maheshwari (Ipca Labs) Mr. Rahul Awasthi (Sun Pharma) Ms. Archana Jatkar (Indian Pharmaceutical Association) Key Takeaways: Logistics: Maharashtra’s distribution network is world-class, but digital transformation is key to staying ahead. API Manufacturing: Local production is gaining momentum cluster models and incentives are making a real impact. R&D: From generics to biosimilars and specialty drugs, the state’s innovation engine is running strong. Policy: The PLI scheme and regulatory reforms are catalyzing growth and investment. Infrastructure: Pharma parks, SEZs, and biotech clusters are powering scale and exports. Cluster Development: Cities like Mumbai, Pune, and Aurangabad are becoming innovation hubs. The consensus?  Maharashtra is setting the pace for India’s pharma and biotech future.   #Pharma #Biotech #Maharashtra #Innovation #Healthcare #API #R&D #Policy #Logistics #ClusterDevelopment #SectoralDiscussion